Home > Insider Trading > Filing (0001209191-10-036944)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1198321	Farah Champsi	One Embarcadero Center Suite 4050 San Francisco CA 94132	No	No	No	Yes
1198323	Jean Deleage	One Embarcadero Center 37Th Floor San Francisco CA 94111	No	No	No	Yes
1198332	Edward Penhoet	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	No	Yes
1257444	Alta Biopharma Partners Iii Lp	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	No	Yes
1280234	Alta Biopharma Management Iii Llc	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	No	Yes
1280238	Alta Embarcadero Biopharma Partners Iii Llc	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	No	Yes
1280265	Alta Biopharma Partners Iii Gmbh & Co Beteiligungs Kg	One Embarcadero Center, Suite 3700 San Francisco CA 94111	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-30	10,910,596	$0.28	10,910,596	No	4	P	Direct
Common Stock	Acquisiton	2010-06-30	732,745	$0.28	732,745	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	268,883	$0.28	268,883	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	4,577,280	$0.00	15,487,876	No	4	C	Direct
Common Stock	Acquisiton	2010-06-30	307,390	$0.00	1,040,135	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2010-06-30	112,800	$0.00	381,683	No	4	C	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Direct
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	457,728	$0.00	4,577,280	$0.00
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	30,739	$0.00	307,390	$0.00
Common Stock	Series A Preferred Stock	Disposition	2010-06-30	11,280	$0.00	112,800	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Alta BioPharma Management III, LLC ("ABMIII") is the general partner of Alta BioPharma Partners III, L.P. ("ABPIII") and the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). Jean Deleage, Farah Champsi, Edward Penhoet, and Edward Hurwitz are directors of ABMIII and managers of Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII" and, along with ABMIII and ABPIIIKG, the "Funds") exercise shared voting and investment power with respect to the securities held by the funds. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuinary interest herein.
These securities are held by ABPIIIKG.
These securities are held by AEBPIII.
The Series A Preferred Stock automatically converted into common stock in accordance with the terms of the applicable Certificate of Designation of the Issuer on a 1-for-10 basis and had no expiration date.